• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and Japan Histone Deacetylase (HDAC) Inhibitors Market Insights, Forecast to 2026

report cover
  • 3 September 2020
  • Healthcare
  • 140 Pages
  • Report Code: 24LS-21427
  • Formate :   
Download FREE Report Sample Download PDF File

Histone Deacetylase Inhibitors -MARKET ADVISORY SERVICES

Histone Deacetylase (HDAC) Inhibitors market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Histone Deacetylase (HDAC) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Histone Deacetylase (HDAC) Inhibitors market is segmented into
Fatty Acid
Hydroxamate
Cyclic Peptide
Benzamide

Segment by Application, the Histone Deacetylase (HDAC) Inhibitors market is segmented into
Treatment of Malignant Tumors
Chronic Disease Treatment
Others

Regional and Country-level Analysis
The Histone Deacetylase (HDAC) Inhibitors market is analysed and market size information is provided by regions (countries).
The key regions covered in the Histone Deacetylase (HDAC) Inhibitors market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Histone Deacetylase (HDAC) Inhibitors Market Share Analysis
Histone Deacetylase (HDAC) Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Histone Deacetylase (HDAC) Inhibitors business, the date to enter into the Histone Deacetylase (HDAC) Inhibitors market, Histone Deacetylase (HDAC) Inhibitors product introduction, recent developments, etc.
The major vendors covered:
4SC
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic
1 Study Coverage
1.1 Histone Deacetylase (HDAC) Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Histone Deacetylase (HDAC) Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate by Type
1.4.2 Fatty Acid
1.4.3 Hydroxamate
1.4.4 Cyclic Peptide
1.4.5 Benzamide
1.5 Market by Application
1.5.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate by Application
1.5.2 Treatment of Malignant Tumors
1.5.3 Chronic Disease Treatment
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue 2015-2026
2.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales 2015-2026
2.2 Global Histone Deacetylase (HDAC) Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Histone Deacetylase (HDAC) Inhibitors Historical Market Size by Region (2015-2020)
2.3.1 Global Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Histone Deacetylase (HDAC) Inhibitors Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Region (2021-2026)
2.4.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Region (2021-2026)

3 Global Histone Deacetylase (HDAC) Inhibitors Competitor Landscape by Players
3.1 Global Top Histone Deacetylase (HDAC) Inhibitors Sales by Manufacturers
3.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Global Histone Deacetylase (HDAC) Inhibitors Manufacturers by Revenue
3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Histone Deacetylase (HDAC) Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Histone Deacetylase (HDAC) Inhibitors Revenue in 2019
3.2.5 Global Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Manufacturers
3.4 Global Histone Deacetylase (HDAC) Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Histone Deacetylase (HDAC) Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Histone Deacetylase (HDAC) Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2015-2020)
4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2015-2020)
4.1.3 Histone Deacetylase (HDAC) Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Histone Deacetylase (HDAC) Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Histone Deacetylase (HDAC) Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Histone Deacetylase (HDAC) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2015-2020)
5.1.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2015-2020)
5.1.3 Histone Deacetylase (HDAC) Inhibitors Price by Application (2015-2020)
5.2 Histone Deacetylase (HDAC) Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Histone Deacetylase (HDAC) Inhibitors Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application
6.1 Japan Histone Deacetylase (HDAC) Inhibitors Market Size YoY Growth 2015-2026
6.1.1 Japan Histone Deacetylase (HDAC) Inhibitors Sales YoY Growth 2015-2026
6.1.2 Japan Histone Deacetylase (HDAC) Inhibitors Revenue YoY Growth 2015-2026
6.1.3 Japan Histone Deacetylase (HDAC) Inhibitors Market Share in Global Market 2015-2026
6.2 Japan Histone Deacetylase (HDAC) Inhibitors Market Size by Players (International and Local Players)
6.2.1 Japan Top Histone Deacetylase (HDAC) Inhibitors Players by Sales (2015-2020)
6.2.2 Japan Top Histone Deacetylase (HDAC) Inhibitors Players by Revenue (2015-2020)
6.3 Japan Histone Deacetylase (HDAC) Inhibitors Historic Market Review by Type (2015-2020)
6.3.1 Japan Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2015-2020)
6.3.2 Japan Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2015-2020)
6.3.3 Japan Histone Deacetylase (HDAC) Inhibitors Price by Type (2015-2020)
6.4 Japan Histone Deacetylase (HDAC) Inhibitors Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Type (2021-2026)
6.4.2 Japan Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Type (2021-2026)
6.4.3 Japan Histone Deacetylase (HDAC) Inhibitors Price Forecast by Type (2021-2026)
6.5 Japan Histone Deacetylase (HDAC) Inhibitors Historic Market Review by Application (2015-2020)
6.5.1 Japan Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2015-2020)
6.5.2 Japan Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2015-2020)
6.5.3 Japan Histone Deacetylase (HDAC) Inhibitors Price by Application (2015-2020)
6.6 Japan Histone Deacetylase (HDAC) Inhibitors Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Application (2021-2026)
6.6.2 Japan Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Application (2021-2026)
6.6.3 Japan Histone Deacetylase (HDAC) Inhibitors Price Forecast by Application (2021-2026)

7 North America
7.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size YoY Growth 2015-2026
7.2 North America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
7.2.1 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2015-2020)
7.2.2 North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size YoY Growth 2015-2026
8.2 Europe Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
8.2.1 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country
8.2.2 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Size YoY Growth 2015-2026
9.2 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
9.2.1 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2015-2020)
9.2.2 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Histone Deacetylase (HDAC) Inhibitors Market Size YoY Growth 2015-2026
10.2 Latin America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
10.2.1 Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country
10.2.2 Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
11.2.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country
11.2.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 4SC
12.1.1 4SC Corporation Information
12.1.2 4SC Description and Business Overview
12.1.3 4SC Sales, Revenue and Gross Margin (2015-2020)
12.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Products Offered
12.1.5 4SC Recent Development
12.2 Acetylon Pharmaceuticals
12.2.1 Acetylon Pharmaceuticals Corporation Information
12.2.2 Acetylon Pharmaceuticals Description and Business Overview
12.2.3 Acetylon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Products Offered
12.2.5 Acetylon Pharmaceuticals Recent Development
12.3 Celleron Therapeutics
12.3.1 Celleron Therapeutics Corporation Information
12.3.2 Celleron Therapeutics Description and Business Overview
12.3.3 Celleron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
12.3.5 Celleron Therapeutics Recent Development
12.4 Chipscreen Biosciences
12.4.1 Chipscreen Biosciences Corporation Information
12.4.2 Chipscreen Biosciences Description and Business Overview
12.4.3 Chipscreen Biosciences Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Products Offered
12.4.5 Chipscreen Biosciences Recent Development
12.5 Chroma Therapeutics
12.5.1 Chroma Therapeutics Corporation Information
12.5.2 Chroma Therapeutics Description and Business Overview
12.5.3 Chroma Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
12.5.5 Chroma Therapeutics Recent Development
12.6 CrystalGenomics
12.6.1 CrystalGenomics Corporation Information
12.6.2 CrystalGenomics Description and Business Overview
12.6.3 CrystalGenomics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Products Offered
12.6.5 CrystalGenomics Recent Development
12.7 Curis
12.7.1 Curis Corporation Information
12.7.2 Curis Description and Business Overview
12.7.3 Curis Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Curis Histone Deacetylase (HDAC) Inhibitors Products Offered
12.7.5 Curis Recent Development
12.8 MEI Pharma
12.8.1 MEI Pharma Corporation Information
12.8.2 MEI Pharma Description and Business Overview
12.8.3 MEI Pharma Sales, Revenue and Gross Margin (2015-2020)
12.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Products Offered
12.8.5 MEI Pharma Recent Development
12.9 Mirati Therapeutics
12.9.1 Mirati Therapeutics Corporation Information
12.9.2 Mirati Therapeutics Description and Business Overview
12.9.3 Mirati Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
12.9.5 Mirati Therapeutics Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Description and Business Overview
12.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Products Offered
12.10.5 Novartis Recent Development
12.11 4SC
12.11.1 4SC Corporation Information
12.11.2 4SC Description and Business Overview
12.11.3 4SC Sales, Revenue and Gross Margin (2015-2020)
12.11.4 4SC Histone Deacetylase (HDAC) Inhibitors Products Offered
12.11.5 4SC Recent Development
12.12 Repligen
12.12.1 Repligen Corporation Information
12.12.2 Repligen Description and Business Overview
12.12.3 Repligen Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Repligen Products Offered
12.12.5 Repligen Recent Development
12.13 TetraLogic
12.13.1 TetraLogic Corporation Information
12.13.2 TetraLogic Description and Business Overview
12.13.3 TetraLogic Sales, Revenue and Gross Margin (2015-2020)
12.13.4 TetraLogic Products Offered
12.13.5 TetraLogic Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Histone Deacetylase (HDAC) Inhibitors Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Histone Deacetylase (HDAC) Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Histone Deacetylase (HDAC) Inhibitors Market Segments

Table 2. Ranking of Global Top Histone Deacetylase (HDAC) Inhibitors Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)

Table 4. Major Manufacturers of Fatty Acid

Table 5. Major Manufacturers of Hydroxamate

Table 6. Major Manufacturers of Cyclic Peptide

Table 7. Major Manufacturers of Benzamide

Table 8. Global Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate by Application 2020-2026 (K MT)

Table 9. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (K MT) & (US$ Million): 2020 VS 2026

Table 10. Global Histone Deacetylase (HDAC) Inhibitors Sales by Regions 2015-2020 (K MT)

Table 11. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Regions (2015-2020)

Table 12. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Regions 2015-2020 (US$ Million)

Table 13. Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Region (2021-2026) (K MT)

Table 14. Global Histone Deacetylase (HDAC) Inhibitors Sales by Manufacturers (2015-2020) (K MT)

Table 15. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Manufacturers (2015-2020)

Table 16. Global Histone Deacetylase (HDAC) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 17. Global Histone Deacetylase (HDAC) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2019)

Table 18. Histone Deacetylase (HDAC) Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)

Table 19. Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers (2015-2020)

Table 20. Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Price (2015-2020) (USD/MT)

Table 21. Histone Deacetylase (HDAC) Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Type

Table 23. Date of International Manufacturers Enter into Histone Deacetylase (HDAC) Inhibitors Market

Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 25. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2015-2020) (K MT)

Table 26. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2015-2020)

Table 27. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2015-2020) (US$ Million)

Table 28. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2015-2020)

Table 29. Histone Deacetylase (HDAC) Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 30. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2021-2026)

Table 31. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2015-2020) (K MT)

Table 32. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2015-2020)

Table 33. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2021-2026)

Table 34. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share Forecast by Application (2021-2026)

Table 35. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2015-2020) (US$ Million)

Table 36. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share Forecast by Application (2021-2026)

Table 37. Japan Histone Deacetylase (HDAC) Inhibitors Sales (K MT) of Key Companies (2015-2020)

Table 38. Japan Histone Deacetylase (HDAC) Inhibitors Sales Share by Company (2015-2020)

Table 39. Japan Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Company (2015-2020)

Table 40. Japan Histone Deacetylase (HDAC) Inhibitors Sales (K MT) by Type (2015-2020)

Table 41. Japan Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2015-2020)

Table 42. Japan Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020)

Table 43. Japan Histone Deacetylase (HDAC) Inhibitors Price (K MT) by Type (2015-2020)

Table 44. Japan Histone Deacetylase (HDAC) Inhibitors Sales (K MT) by Type (2021-2026)

Table 45. Japan Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2021-2026)

Table 46. Japan Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026)

Table 47. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2021-2026)

Table 48. Japan Histone Deacetylase (HDAC) Inhibitors Price (K MT) by Type (2021-2026)

Table 49. Japan Histone Deacetylase (HDAC) Inhibitors Sales (K MT) by Application (2015-2020)

Table 50. Japan Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2015-2020)

Table 51. Japan Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020)

Table 52. Japan Histone Deacetylase (HDAC) Inhibitors Sales (K MT) by Application (2021-2026)

Table 53. Japan Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2021-2026)

Table 54. Japan Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026)

Table 55. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Share by Application (2021-2026)

Table 56. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2015-2020) (K MT)

Table 57. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2015-2020)

Table 58. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2015-2020) (US$ Million)

Table 59. North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2015-2020)

Table 60. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2015-2020) (K MT)

Table 61. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2015-2020)

Table 62. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2015-2020) (US$ Million)

Table 63. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2015-2020)

Table 64. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2015-2020) (K MT)

Table 65. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2015-2020)

Table 66. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2015-2020) (US$ Million)

Table 67. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2015-2020)

Table 68. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2015-2020) (K MT)

Table 69. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2015-2020)

Table 70. Latin Americaa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2015-2020) (US$ Million)

Table 71. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2015-2020)

Table 72. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2015-2020) (K MT)

Table 73. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2015-2020)

Table 74. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2015-2020) (US$ Million)

Table 75. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2015-2020)

Table 76. 4SC Corporation Information

Table 77. 4SC Description and Business Overview

Table 78. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 79. 4SC Histone Deacetylase (HDAC) Inhibitors Product

Table 80. 4SC Recent Development

Table 81. Acetylon Pharmaceuticals Corporation Information

Table 82. Acetylon Pharmaceuticals Description and Business Overview

Table 83. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 84. Acetylon Pharmaceuticals Product

Table 85. Acetylon Pharmaceuticals Recent Development

Table 86. Celleron Therapeutics Corporation Information

Table 87. Celleron Therapeutics Description and Business Overview

Table 88. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 89. Celleron Therapeutics Product

Table 90. Celleron Therapeutics Recent Development

Table 91. Chipscreen Biosciences Corporation Information

Table 92. Chipscreen Biosciences Description and Business Overview

Table 93. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 94. Chipscreen Biosciences Product

Table 95. Chipscreen Biosciences Recent Development

Table 96. Chroma Therapeutics Corporation Information

Table 97. Chroma Therapeutics Description and Business Overview

Table 98. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 99. Chroma Therapeutics Product

Table 100. Chroma Therapeutics Recent Development

Table 101. CrystalGenomics Corporation Information

Table 102. CrystalGenomics Description and Business Overview

Table 103. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 104. CrystalGenomics Product

Table 105. CrystalGenomics Recent Development

Table 106. Curis Corporation Information

Table 107. Curis Description and Business Overview

Table 108. Curis Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 109. Curis Product

Table 110. Curis Recent Development

Table 111. MEI Pharma Corporation Information

Table 112. MEI Pharma Description and Business Overview

Table 113. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 114. MEI Pharma Product

Table 115. MEI Pharma Recent Development

Table 116. Mirati Therapeutics Corporation Information

Table 117. Mirati Therapeutics Description and Business Overview

Table 118. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 119. Mirati Therapeutics Product

Table 120. Mirati Therapeutics Recent Development

Table 121. Novartis Corporation Information

Table 122. Novartis Description and Business Overview

Table 123. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 124. Novartis Product

Table 125. Novartis Recent Development

Table 126. Onxeo Corporation Information

Table 127. Onxeo Description and Business Overview

Table 128. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 129. Onxeo Product

Table 130. Onxeo Recent Development

Table 131. Repligen Corporation Information

Table 132. Repligen Description and Business Overview

Table 133. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 134. Repligen Product

Table 135. Repligen Recent Development

Table 136. TetraLogic Corporation Information

Table 137. TetraLogic Description and Business Overview

Table 138. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 139. TetraLogic Product

Table 140. TetraLogic Recent Development

Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 142. Key Challenges

Table 143. Market Risks

Table 144. Main Points Interviewed from Key Histone Deacetylase (HDAC) Inhibitors Players

Table 145. Histone Deacetylase (HDAC) Inhibitors Customers List

Table 146. Histone Deacetylase (HDAC) Inhibitors Distributors List

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Histone Deacetylase (HDAC) Inhibitors Product Picture

Figure 2. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type in 2020 & 2026

Figure 3. Fatty Acid Product Picture

Figure 4. Hydroxamate Product Picture

Figure 5. Cyclic Peptide Product Picture

Figure 6. Benzamide Product Picture

Figure 7. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application in 2020 & 2026

Figure 8. Treatment of Malignant Tumors

Figure 9. Chronic Disease Treatment

Figure 10. Others

Figure 11. Histone Deacetylase (HDAC) Inhibitors Report Years Considered

Figure 12. Global Histone Deacetylase (HDAC) Inhibitors Market Size 2015-2026 (US$ Million)

Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Sales 2015-2026 (K MT)

Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2015-2020)

Figure 16. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region in 2019

Figure 17. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2015-2020)

Figure 18. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region in 2019

Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Manufacturer in 2019

Figure 20. The Top 10 and 5 Players Market Share by Histone Deacetylase (HDAC) Inhibitors Revenue in 2019

Figure 21. Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2015-2020)

Figure 23. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type in 2019

Figure 24. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2015-2020)

Figure 25. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type in 2019

Figure 26. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Price Range (2015-2020)

Figure 27. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2015-2020)

Figure 28. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application in 2019

Figure 29. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2015-2020)

Figure 30. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application in 2019

Figure 31. Japan Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate 2015-2026 (K MT)

Figure 32. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate 2015-2026 (US$ Million)

Figure 33. Japan Histone Deacetylase (HDAC) Inhibitors Market Share in Global Market 2015-2026

Figure 34. Japan 5 and 10 Largest Histone Deacetylase (HDAC) Inhibitors Players Market Share by Revenue in Histone Deacetylase (HDAC) Inhibitors in 2019

Figure 35. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2015-2020)

Figure 36. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate by Type in 2015 & 2019

Figure 37. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Share by Application (2015-2020)

Figure 38. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate by Application in 2015 & 2019

Figure 39. North America Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate 2015-2020 (K MT)

Figure 40. North America Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)

Figure 41. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country in 2019

Figure 42. North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country in 2019

Figure 43. U.S. Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 44. U.S. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Canada Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 46. Canada Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. Europe Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate 2015-2020 (K MT)

Figure 48. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)

Figure 49. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country in 2019

Figure 50. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country in 2019

Figure 51. Germany Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 52. Germany Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. France Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 54. France Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. U.K. Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 56. U.K. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Italy Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 58. Italy Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Russia Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 60. Russia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate 2015-2020 (K MT)

Figure 62. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)

Figure 63. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region in 2019

Figure 64. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region in 2019

Figure 65. China Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 66. China Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. Japan Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 68. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. South Korea Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 70. South Korea Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. India Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 72. India Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Australia Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 74. Australia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Taiwan Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 76. Taiwan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Indonesia Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 78. Indonesia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Thailand Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 80. Thailand Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Malaysia Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 82. Malaysia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Philippines Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 84. Philippines Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Vietnam Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 86. Vietnam Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 87. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate 2015-2020 (K MT)

Figure 88. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)

Figure 89. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country in 2019

Figure 90. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country in 2019

Figure 91. Mexico Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 92. Mexico Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Brazil Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 94. Brazil Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Argentina Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 96. Argentina Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 97. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate 2015-2020 (K MT)

Figure 98. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)

Figure 99. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country in 2019

Figure 100. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country in 2019

Figure 101. Turkey Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 102. Turkey Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 104. Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. U.A.E Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate (2015-2020) (K MT)

Figure 106. U.A.E Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. Porter's Five Forces Analysis

Figure 108. Histone Deacetylase (HDAC) Inhibitors Value Chain

Figure 109. Channels of Distribution

Figure 110. Distributors Profiles

Figure 111. Bottom-up and Top-down Approaches for This Report

Figure 112. Data Triangulation

Figure 113. Key Executives Interviewed

4SC

Acetylon Pharmaceuticals

Celleron Therapeutics

Chipscreen Biosciences

Chroma Therapeutics

CrystalGenomics

Curis

MEI Pharma

Mirati Therapeutics

Novartis

Onxeo

Repligen

TetraLogic

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3315

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase